Literature DB >> 30554410

The role of robotic aortic lymphadenectomy in gynecological cancer: surgical and oncological outcome in a single institution experience.

Valerio Gallotta1, Alex Federico2, Khaled Gaballa3, Marco D'Indinosante2, Carmine Conte1, Maria Teresa Giudice2, Angelica Naldini1, Claudio Lodoli4, Stefano Rotolo4, Valeria Gallucci1, Lucia Tortorella1, Bruno Romanò5, Giovanni Scambia1,2, Gabriella Ferrandina1,2.   

Abstract

BACKGROUND AND
OBJECTIVE: This study aims to investigate the surgical outcomes observed in robotic transperitoneal aortic lymphadenectomy (AL) in gynecological cancer patients.
METHODS: Retrospective data were collected and analyzed on 71 patients undergoing robotic surgical procedures for gynecological cancers, including transperitoneal AL, between December 2014 and February 2018 at the Catholic University of the Sacred Heart, Rome, Italy.
RESULTS: Median age of the sample population was 50 years (range, 26-76 years). The median operative time was 210 minutes (range, 75-480 minutes), the median estimated blood loss was 50 ml (range, 20-300 ml). The number of para-aortic nodes removed was 12 (range, 7-43). In the whole series, 13 patients (18.3%) had at least one metastatic node. Overall, 10 patients (14.1%) experienced any grade early postoperative complications. Three patients experienced more than one complication. Three intraoperative complications occurred with two cases of vascular injury. Conversion to laparotomy was necessary for one patient (1.4%).
CONCLUSIONS: The present study shows the safety and adequacy of robotic transperitoneal AL as surgical staging step for gynecological cancers in terms of perioperative and postoperative outcomes.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  gynecological cancers; innovative technologies in surgery; minimally invasive surgery; personalized medicine; robotic surgery

Mesh:

Year:  2018        PMID: 30554410     DOI: 10.1002/jso.25335

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Comparison of Laparoscopy and Laparotomy for Para-Aortic Lymphadenectomy in Women With Presumed Stage I-II High-Risk Endometrial Cancer.

Authors:  E Sun Paik; Seung Hun Baek; Jun Hyeok Kang; Soo Young Jeong; Myeong Seon Kim; Woo Young Kim; Yoo-Young Lee; Chel Hun Choi; Jeong-Won Lee; Byoung-Gie Kim; Duk-Soo Bae; Tae-Joong Kim
Journal:  Front Oncol       Date:  2020-04-07       Impact factor: 6.244

2.  Surgical Outcomes of Transperitoneal Para-Aortic Lymphadenectomy Compared With Extraperitoneal Approach in Gynecologic Cancers: A Systematic Review and Meta-Analysis.

Authors:  Kun-Peng Li; Xian-Zhong Deng; Tao Wu
Journal:  Front Surg       Date:  2021-12-21

3.  Systematic Review of Olaparib in the Treatment of Recurrent Platinum Sensitive Ovarian Cancer.

Authors:  Qian Chen; Xiaoli Li; Zhen Zhang; Tong Wu
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

4.  The Transumbilical Laparoendoscopic Single-Site Extraperitoneal Approach for Pelvic and Para-Aortic Lymphadenectomy: A Technique Note and Feasibility Study.

Authors:  Shiyi Peng; Ying Zheng; Fan Yang; Kana Wang; Sijing Chen; Yawen Wang
Journal:  Front Surg       Date:  2022-04-15

5.  Robotic Staging of Cervical Cancer With Simultaneous Detection of Primary Pelvic and Secondary Para-Aortic Sentinel Lymph Nodes: Reproducibility in a First Case Series.

Authors:  Philippe Van Trappen; Eveline De Cuypere; Nele Claes; Sarah Roels
Journal:  Front Surg       Date:  2022-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.